FAQ

YOD1 gene

Known as: OTUD2, YOD1, YOD1 deubiquitinase 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2015-2017
01220152017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
YOD1 attenuates neurogenic proteotoxicity through its deubiquitinating activity.
Ubiquitination, a fundamental post-translational modification of intracellular proteins, is enzymatically reversed by… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2017
2017
Deubiquitinase YOD1 potentiates YAP/TAZ activities through enhancing ITCH stability.
Hippo signaling controls the expression of genes regulating cell proliferation and survival and organ size. The regulation of… (More)
Is this relevant?
2017
2017
Deubiquitinase YOD1: the potent activator of YAP in hepatomegaly and liver cancer
Advances in the understanding of the Hippo signaling as a key regulatory pathway of proliferation and apoptosis have provided… (More)
  • figure 1
Is this relevant?
2015
2015
MicroRNA-373 functions as an oncogene and targets YOD1 gene in cervical cancer.
miR-373 was reported to be elevated in several tumors; however, the role of miR-373 in cervical cancer has not been investigated… (More)
Is this relevant?
2015
2015
The VCP/p97 and YOD1 Proteins Have Different Substrate-dependent Activities in Endoplasmic Reticulum-associated Degradation (ERAD).
Endoplasmic reticulum-associated degradation (ERAD) is an essential quality control mechanism of the folding state of proteins in… (More)
  • figure 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?